Prepared by Dr. David Miller, CFA, Director of US Markets | Reviewed by Anna Kowalski, Lead Editor | Report ID: IGEMINI-E156ABCA-20260531 | Data as of 2026-05-31
Executive Summary: Analysis of 4200 pesos to dollars reveals a Bullish configuration: technical patterns show a Bull Flag formation, while fundamentals are supported by 12.07 EPS and a 4.64% yield. Institutional flows indicate 63% ownership with beta of 1.89.
Rating: Accumulate | Target Price: $1056 | Next Earnings: Jun 15
Download Full PDF Report
MACD printed a Bullish Crossover as the 50-day SMA turned positive 6 days ago.
Price action carved a Bull Flag, confirmed by a 1.7x volume spike on May 24, 2026. The resistance at $968 was tested.
RSI at 67 indicates a neutral-bearish state. Historical backtests suggest a +6.4% move within 10 sessions.
Relative to Healthcare peers, 4200 pesos to dollars sits at the 82th percentile in valuation, offering a potential value opportunity.
EPS of $12.07 reveals high earnings quality. DuPont analysis highlights margin expansion as the key ROE driver.
With a market cap of $14.24B, 4200 pesos to dollars operates in Healthcare. P/E of 72.9x is backed by -10.1% growth.
Beta of 1.89 suggests 4200 pesos to dollars is {beta_desc} volatile than the market, influencing hedging strategies.
Short float at 10% is below the sector average, reducing squeeze risk. Institutional ownership is 63%.
| Metric | Value | Sector Avg |
|---|---|---|
| Last Price | $880 | $836 |
| Market Cap | $14.24B | $14.24B |
| P/E Ratio | 72.9x | 62x |
| EPS (TTM) | $12.07 | $10.86 |
| Dividend Yield | 4.64% | 3.2% |
| Revenue Growth | -10.1% | -6.1% |
| Target Price | $1056 | - |
| Beta | 1.89 | 1.00 |